Mr. Wang, aged 56, was appointed as an independent non-executive director of the Company in 2012. Mr. Wang is currently the CEO of Beijing CHNMED Pharmaceutical Technology Development Co., Ltd and managing director of Beijing CHNMED Pharmaceutical Consulting Co., Ltd.. Mr. Wang graduated from Beijing Institute of Iron and Steel and has extensive experience in pharmaceutical policy research and consulting. Mr. Wang is currently the vice-chairman of Chinese Pharmaceutical Enterprises Association and China National Association of Pharmaceutical and Medical Equipment Technical Market.Mr. Wang is also an independent director of Hainan Shuangcheng Pharmaceutical Co., Ltd. (listed on Shenzhen Stock Exchange), Guangxi Linzhou Pharmaceutical Co., Ltd. (listed on Shanghai Stock Exchange) and Henan Taloph Pharmaceutical Stock Co., Ltd. (listed on Shanghai Stock Exchange). Mr. Wang was also appointed as independent director of Jiuzhitang Co., Ltd. (listed on Shenzhen Stock Exchange) on 12 May 2016.Mr. Wang retired as an independent director of Jiangxu Wuzhong Industrial Co., Ltd. (listed on Shanghai Stock Exchange) on 5 April 2016

pharmaceutical industry